BR0011469A - Gm-csf equina - Google Patents
Gm-csf equinaInfo
- Publication number
- BR0011469A BR0011469A BR0011469-3A BR0011469A BR0011469A BR 0011469 A BR0011469 A BR 0011469A BR 0011469 A BR0011469 A BR 0011469A BR 0011469 A BR0011469 A BR 0011469A
- Authority
- BR
- Brazil
- Prior art keywords
- csf
- equine
- equina
- adjuvant
- vectors
- Prior art date
Links
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 title abstract 6
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 title abstract 6
- 241000283073 Equus caballus Species 0.000 title abstract 5
- 239000002671 adjuvant Substances 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Patente de Invenção: "GM-CSF EQuINA". A presente invenção refere-se a GM-CSF eq³ina, à seq³ência nucleotídica codificando para a GM-CSF eq³ina e sua seq³ência em amino-ácidos, assim como sua utilização como adjuvante em vacinação eq³ina e como estimulante não específico da imunidade. Composições contendo a GM-CSF eq³ina ou vetores que expressam a GM-CSF in vivo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13884399P | 1999-06-10 | 1999-06-10 | |
| PCT/FR2000/001590 WO2000077210A1 (fr) | 1999-06-10 | 2000-06-08 | Gm-csf equin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0011469A true BR0011469A (pt) | 2002-03-05 |
Family
ID=22483915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0011469-3A BR0011469A (pt) | 1999-06-10 | 2000-06-08 | Gm-csf equina |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6645740B1 (pt) |
| EP (1) | EP1185655B1 (pt) |
| JP (1) | JP2003502044A (pt) |
| AT (1) | ATE444366T1 (pt) |
| AU (1) | AU781107B2 (pt) |
| BR (1) | BR0011469A (pt) |
| CA (1) | CA2375619C (pt) |
| CZ (1) | CZ302009B6 (pt) |
| DE (1) | DE60043062D1 (pt) |
| ES (1) | ES2333093T3 (pt) |
| NZ (1) | NZ515989A (pt) |
| PL (1) | PL205608B1 (pt) |
| RU (1) | RU2279476C2 (pt) |
| WO (1) | WO2000077210A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2823222B1 (fr) | 2001-04-06 | 2004-02-06 | Merial Sas | Vaccin contre le virus de la fievre du nil |
| US20040091503A1 (en) | 2002-08-20 | 2004-05-13 | Genitrix, Llc | Lectin compositions and methods for modulating an immune response to an antigen |
| EP2158917A1 (en) | 2002-09-19 | 2010-03-03 | The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services | P.ariasi polypeptides, P.perniciosus polypeptides and methods of use |
| ATE429487T1 (de) | 2002-10-29 | 2009-05-15 | Us Gov Health & Human Serv | Lutzomyia longipalpis-polypeptide und verwendungsverfahren |
| MXPA06005424A (es) | 2003-11-13 | 2007-01-25 | Univ Georgia Res Found | Metodos para caracterizar virus de enfermedad bursal infecciosa. |
| DE602006013117D1 (de) | 2005-04-25 | 2010-05-06 | Merial Ltd | Nipah-virus-impfstoffe |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| UA100370C2 (uk) | 2006-12-11 | 2012-12-25 | Мериал Лимитед | Спосіб вакцинації птахів проти salmonella |
| CN103768588A (zh) | 2008-05-08 | 2014-05-07 | 梅里亚有限公司 | 使用白蛉唾液免疫原的利什曼原虫疫苗 |
| US20130197612A1 (en) | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
| CA2842055C (en) | 2011-07-20 | 2019-04-02 | Merial Limited | Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene |
| MX355443B (es) | 2012-03-20 | 2018-04-18 | Merial Inc | Vacuna de herpesvirus-1 equino recombinante que contiene glicoproteina c mutada y usos de la misma. |
| AU2013308623B2 (en) | 2012-08-30 | 2017-03-02 | Merial, Inc. | Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5162111A (en) * | 1986-07-30 | 1992-11-10 | Grabstein Kenneth H | Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor |
| WO1992005255A1 (en) | 1990-09-13 | 1992-04-02 | Commonwealth Scientific And Industrial Research Organisation | Ovine cytokine genes |
| WO1994001133A1 (en) | 1992-07-08 | 1994-01-20 | Schering Corporation | Use of gm-csf as a vaccine adjuvant |
| AUPM543894A0 (en) * | 1994-05-04 | 1994-05-26 | Commonwealth Scientific And Industrial Research Organisation | An adjuvant |
| FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
-
2000
- 2000-06-07 US US09/589,460 patent/US6645740B1/en not_active Expired - Lifetime
- 2000-06-08 AT AT00940472T patent/ATE444366T1/de not_active IP Right Cessation
- 2000-06-08 BR BR0011469-3A patent/BR0011469A/pt not_active Application Discontinuation
- 2000-06-08 WO PCT/FR2000/001590 patent/WO2000077210A1/fr active Application Filing
- 2000-06-08 NZ NZ515989A patent/NZ515989A/xx not_active IP Right Cessation
- 2000-06-08 CZ CZ20014377A patent/CZ302009B6/cs not_active IP Right Cessation
- 2000-06-08 PL PL352484A patent/PL205608B1/pl unknown
- 2000-06-08 JP JP2001503654A patent/JP2003502044A/ja active Pending
- 2000-06-08 RU RU2002100209/13A patent/RU2279476C2/ru active
- 2000-06-08 EP EP00940472A patent/EP1185655B1/fr not_active Expired - Lifetime
- 2000-06-08 ES ES00940472T patent/ES2333093T3/es not_active Expired - Lifetime
- 2000-06-08 CA CA2375619A patent/CA2375619C/en not_active Expired - Lifetime
- 2000-06-08 AU AU55403/00A patent/AU781107B2/en not_active Expired
- 2000-06-08 DE DE60043062T patent/DE60043062D1/de not_active Expired - Lifetime
-
2003
- 2003-07-07 US US10/614,481 patent/US7250161B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2333093T3 (es) | 2010-02-17 |
| ATE444366T1 (de) | 2009-10-15 |
| DE60043062D1 (de) | 2009-11-12 |
| CZ20014377A3 (cs) | 2002-04-17 |
| WO2000077210A1 (fr) | 2000-12-21 |
| US20050059121A1 (en) | 2005-03-17 |
| US6645740B1 (en) | 2003-11-11 |
| PL205608B1 (pl) | 2010-05-31 |
| JP2003502044A (ja) | 2003-01-21 |
| EP1185655B1 (fr) | 2009-09-30 |
| PL352484A1 (en) | 2003-08-25 |
| AU5540300A (en) | 2001-01-02 |
| NZ515989A (en) | 2003-06-30 |
| CA2375619A1 (en) | 2000-12-21 |
| EP1185655A1 (fr) | 2002-03-13 |
| RU2279476C2 (ru) | 2006-07-10 |
| US7250161B2 (en) | 2007-07-31 |
| CA2375619C (en) | 2013-01-22 |
| CZ302009B6 (cs) | 2010-09-01 |
| AU781107B2 (en) | 2005-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI9912663B1 (pt) | vacina contra cáncer e polipeptìdeo. | |
| BR0011469A (pt) | Gm-csf equina | |
| IL195338A (en) | An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use | |
| RS50364B (sr) | Modifikovani faktor viii | |
| CY1106350T1 (el) | Εμβολιο φυματιωσης | |
| BR9814276A (pt) | Antìgenos de superfìcie | |
| DE69938302D1 (de) | Neisseria meningitidis antigene und zusammenstellungen | |
| BR9916896A (pt) | Diaril aminas substituìdas com 1-heterociclo | |
| DE69941567D1 (de) | Antigene aus neisseria meningitidis | |
| WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
| CU23608A3 (es) | Vacuna para la tuberculosis ureasa deficiente con eficacia mejorada | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| DE69938240D1 (de) | Neuer g-protein-gekoppelter rezeptor | |
| DK1279677T3 (da) | GD3-mimetiske peptider | |
| NO972313D0 (no) | Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav | |
| BR0208786A (pt) | Métodod para identificação de proteìnas de bactérias intracelulares | |
| BR0013574A (pt) | Antìgeno vacina de moraxella | |
| BR9712546A (pt) | Adjuvante, notadamente sob a forma de uma emulsão contendo um cátion metálico trivalente e composição vacinal que a compreende | |
| ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
| BR0308180A (pt) | protéinas de superfìcie de leptospira | |
| BR9905780A (pt) | Antìgenos vacinais de leptospira para prevenção da laptospirose | |
| BR9915537A (pt) | Gene prv-1 e sua utilização | |
| BR9812869A (pt) | Processo para a preparação de benzofuranonas eventualmente substituìdas | |
| HUP0102540A2 (hu) | Új angiotenzin-receptor, eljárás előállítására és alkalmazása | |
| BR0107799A (pt) | Proteìna de interação de wt1 wtip |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B15V | Prolongation of time limit allowed |
Free format text: RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 70 DIAS, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04. |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART .8O COMBINADO COM ART. 13 DA LPI. |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |